Market Overview

'As The Dust Settles,' Deutsche Bank Says Bayer Remains A Buy

Share:
'As The Dust Settles,' Deutsche Bank Says Bayer Remains A Buy
Related BAYRY
Portola Pharma Rips 20% Higher After FDA Approves Andexxa Antidote
Monsanto Displays Robust Research & Development Moves
Bloomberg: Bayer-Monsanto to win U.S. antitrust OK next week (Seeking Alpha)
Related MON
Warren Buffett Pushing More Cash To Equities; 'Big 5' Stocks Still At The Top
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolio
Ashburton (Jersey) Ltd Buys SPDR S&P 5……, The Kraft Heinz Co, Philip Morris ... (GuruFocus)

Bayer AG (ADR) (OTCMKTS: BAYRY) has made a $62bn offer for Monsanto Company (NYSE: MON). Deutsche Bank’s Tim Race maintained a Buy rating for Bayer, with a price target of €124. The analyst commented that the combination of the two companies “makes both operational and financial sense.”

Investors did not seem to favor Bayer’s offer for Monsanto. Bayer’s shares have tumbled more than 15 percent on concerns related to the size, opportunity cost, financing structure as well as the differences in opinion between management and investors on the company’s strategic direction.

The news is out and shares have responded to it, analyst Tim Race said, while adding “as the dust settles we continue to see value in the business.”

Related Link: Bayer's Bid For Monsanto Might Bring "Short-Term Pain, Long-Term Gain"

Good Fit

Bayer’s shares could be significantly volatile in the near term, while the negotiations for Monsanto play out. Race mentioned, however, that the proposed deal was a good strategic fit and is expected to be 11-13 percent EPS accretive in 2019-2020, which would contribute towards an annual growth rate of low-to-mid-teen for earnings.

“In our view, Bayer was already discounted due to uncertainties in its growth from Healthcare longer-term. This deal does not directly solve these, but it potentially grows earnings through an alternative source,” the analyst added.

Latest Ratings for BAYRY

DateFirmActionFromTo
Aug 2016CitigroupUpgradesNeutralBuy
Dec 2014Morgan StanleyUpgradesEqual-WeightOverweight

View More Analyst Ratings for BAYRY
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Tim RaceAnalyst Color Long Ideas Reiteration Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (MON + BAYRY)

View Comments and Join the Discussion!